Literature DB >> 2139757

Red cell superoxide dismutase, glutathione peroxidase and catalase in Down syndrome patients with and without manifestations of Alzheimer disease.

M E Percy1, A J Dalton, V D Markovic, D R McLachlan, J T Hummel, A C Rusk, D F Andrews.   

Abstract

The activities of red blood cell enzymes that scavenge the superoxide radical and hydrogen peroxide were measured in severely to profoundly retarded adult Down syndrome (DS) patients with and without manifestations of Alzheimer disease (AD), and control individuals matched for sex, age, and time of blood sampling. Cu,Zn superoxide dismutase (SOD-1) and glutathione peroxidase (GSHPx) activities were significantly elevated (1.39-fold and 1.24-fold, respectively) in DS individuals without AD. When an adjustment was made for the SOD gene dosage effect, DS patients with AD manifestations had significantly lower SOD levels than the matched control individuals. In contrast, DS patients with and without AD had a similar elevation in GSHPx (an adaptive phenomenon). The mean catalase (CAT) activity was no different in DS and control individuals; however, in a paired regression analysis, DS patients without AD had marginally lower CAT activity than control individuals, whereas DS patients with AD had slightly but not significantly higher CAT activity. Thus, AD manifestations in this DS population are associated with changes in the red cell oxygen scavenging processes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139757     DOI: 10.1002/ajmg.1320350403

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  9 in total

1.  Immunohistochemical evidence of oxidative [corrected] stress in Alzheimer's disease.

Authors:  M A Pappolla; R A Omar; K S Kim; N K Robakis
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

2.  Changed serum trace element profile in Down's syndrome.

Authors:  J Kadrabová; A Madáric; M Sustrová; E Ginter
Journal:  Biol Trace Elem Res       Date:  1996-09       Impact factor: 3.738

3.  Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease.

Authors:  Fabio Di Domenico; Gilda Pupo; Antonella Tramutola; Alessandra Giorgi; Maria Eugenia Schininà; Raffaella Coccia; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2014-03-25       Impact factor: 7.376

4.  Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Authors:  C D Smith; J M Carney; P E Starke-Reed; C N Oliver; E R Stadtman; R A Floyd; W R Markesbery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  Analysis of the influences of short-term levosimendan exposure on oxidant/antioxidant status and trace-element levels in the physiological status of the thoracic aorta of rats.

Authors:  Cemalettin Aydin; Yasin Ay; Halil Basel; Servet Kavak; Bekir Inan; Hava Bektaş; Hasan Ali Gümrükçüoğlu; Hasan Ekim; Halit Demir
Journal:  J Membr Biol       Date:  2012-07-29       Impact factor: 1.843

6.  Systemic oxidative stress associated with the neurological diseases of aging.

Authors:  Jorge A Serra; Raúl O Domínguez; Enrique R Marschoff; Eduardo M Guareschi; Arturo L Famulari; Alberto Boveris
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

7.  Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain.

Authors:  T K Makar; A J Cooper; B Tofel-Grehl; H T Thaler; J P Blass
Journal:  Neurochem Res       Date:  1995-06       Impact factor: 3.996

Review 8.  Peripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse.

Authors:  Dominik Szwajgier; Ewa Baranowska-Wójcik; Joanna Grzelczyk; Wioletta Żukiewicz-Sobczak
Journal:  Dis Markers       Date:  2021-06-28       Impact factor: 3.434

9.  The effects of levosimendan exposure on oxidant/antioxidant status and trace element levels in the pulmonary artery of rats.

Authors:  Yasin Ay; Cemalettin Aydın; Halil Basel; Hava Bektaş; Gülay Bülüt; Bekir Inan; Nuray Kahraman Ay; Ismail Demir
Journal:  J Membr Biol       Date:  2013-05-15       Impact factor: 1.843

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.